FDA Approves Dsuvia (sufentanil) Sublingual Tablets for Severe Pain

REDWOOD CITY, Calif., Nov. 2, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (AcelRx) (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in a medically supervised...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news